"Any cancer patient out there who thinks they can go through all of this alone is completely wrong"
Ivan Cruser wants cancer patients like himself to never give up hope. The 61-year-old Sauk Rapids man had some of his stem cells removed briefly in order to receive higher-than-average doses of chemotherapy, ... via St. Cloud Times
Filed under: Cancer Survivors, Today, I Am Grateful
The following post is one of a series of posts appearing Monday through Friday on The Cancer Blog. This feature -- Today, I am grateful -- allows me to share with readers my appreciation for all the treasures in my life, both big and small. In my post-cancer world, I find It healing for my soul to be mindful of the good in my life. It is my pleasure to share my gratitude with you. My cancer had not spread. My lymph nodes were clean; my margins clear. I still had to endure chemotherapy, radiation, and a year-long Herceptin therapy. But I didn't have to worry that my cancer was knowingly gaining momentum, only to land elsewhere.
For almost three years, my cancer has not returned.
Today, I am grateful my breast cancer did not spread.
Filed under: Daily news
According to an article in the Chicago Tribune, until recently, medical mistakes were rarely discussed and almost never admitted to patients due to physicians' pride and fear of malpractice lawsuits. However, that mindset may be beginning to change, as leading patient safety organizations call for full disclosure of medical errors and some hospitals change to an "honesty is best" policy.Filed under: Breast Cancer, Research
Studies are showing that low-dose radiation treatments may increase the risk of breast cancer. This may include diagnostic chest x-rays, as well as other treatments like radiotherapy for skin conditions. The findings aren't conclusive thus far but they warrant further investigation, according to this article. Filed under: Leukemia
FTY720 does not directly target the BCR-ABL kinase, but instead activates phosphatase 2A (PP2A) which is a tumor suppressor that is inactivated by BCR-ABL. There were no adverse effects seen in the mice and no adverse effects in clinical trials for multiple sclerosis.
The authors believe that this study shows strong support for the use of FTY720 as a novel therapeutic for CML and ALL that is not responsive to current treatments with kinase inhibitors.
Read | Permalink | Email this | Linking Blogs | CommentsFiled under: Research
An asbestos-related cancer called mesothelioma is a particularly deadly cancer that has little help these days from the global medical community (probably due to not being a highly popular cancer).Filed under: Bladder Cancer, Prevention
Non-steroidal anti-inflammatory drugs (NSAIDs), especially aspirin, may decrease the risk of bladder cancer according to a new study led by Dr. Margaret Karagas of Dartmouth Medical School.
